Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (1 ops.)
Latest filing published 19 Feb 2025 for Catalyst Pharmaceuticals, INC.. Read the official filing
Filing timeline
BuySaleCharles B. O'Keeffe
Insider track record
Disclosed buys
2
Disclosed sells
1
Signal history
Closed purchases
Market purchases
2
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Since each purchase
- +7.6%Entry US$1.05 · Close at T+365 US$1.13
- -39.8%Entry US$1.86 · Close at T+365 US$1.12
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Charles B. O'Keeffe: trading record in brief
This profile gathers the share dealings of Charles B. O'Keeffe in Catalyst Pharmaceuticals, Inc., where the filings describe the role as board member. We count 15 filings; the first trade dates from 8 January 2016 and the latest from 14 February 2025.
On the open market, the record shows 2 purchases and 1 sale worth €1.4M. The amount is not disclosed for 2 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 12 option exercises.
The record was last updated on 19 February 2025 with an option exercise in Catalyst Pharmaceuticals, Inc. The most recent open-market purchase was published on 1 February 2016, 3,911 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Charles B. O'Keeffe
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
4,000 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-25-000071:0
1,333 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-24-000543:0
1,413 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-24-000506:0
4,000 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-24-000104:0
60,000 shares@ US$1.133.6% of flowCommon Stock, par value $0.001 per shareSEC:0001161697-24-000026:0
1,333 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-23-000651:0
4,000 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-23-000133:0
50,000 shares@ US$0.792.1% of flowCommon stock, par value $0.001 per shareSEC:0001161697-23-000086:0
1,334 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-22-000577:0
87,985 shares@ US$16.03780.5% of flowCommon stock, par value $0.001 per shareSEC:0001161697-22-000554:0
40,000 shares@ US$2.535.9% of flowCommon stock, par value $0.001 per shareSEC:0001161697-22-000401:0
1,333 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-21-000555:0
50,000 shares@ US$3.127.8% of flowCommon stock, par value $0.001 per shareSEC:0001161697-21-000389:0
5,000 sharesCommon stock, par value $0.001 per shareSEC:0001161697-16-000655:0
Canonical exit: 1 May 2016 (T+90)
5,000 sharesCommon stock, par value $0.001 per shareSEC:0001161697-16-000612:0
Canonical exit: 7 Apr 2016 (T+90)
15 of 15 declarations
